InvestorsHub Logo
Followers 6
Posts 107
Boards Moderated 0
Alias Born 03/28/2013

Re: None

Tuesday, 02/18/2020 4:31:22 AM

Tuesday, February 18, 2020 4:31:22 AM

Post# of 426304
Citi Upgrades Amarin Corporation (AMRN) to Buy, Anticipates Strong Sales Growth

February 18, 2020 1:46 AM

Citi analyst Joel Beatty upgraded Amarin Corporation (NASDAQ: AMRN) from Neutral to Buy with a price target of $24.00 (from $27.00).

The analyst comments "We still believe Vascepa sales will accelerate strongly over the next couple years. With AMRN trading ~27% lower since November, we see now as an attractive time to buy. Also, we believe AMRN will likely emerge from the ongoing IP litigation with Vascepa exclusivity largely intact "
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News